Skip to main content
OpenTrials

Clinical trial condition

Neurobehavioral Manifestations

Explore clinical trials studying Neurobehavioral Manifestations. Study availability and eligibility vary by location and protocol.

6,862 public trials 1,212 recruiting studies
Refine in advanced search Browse all conditions

Neurobehavioral Manifestations trial results

Completed

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

NCT00823368

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

NCT01325220

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 28 locations
View Trial Details
Completed

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

NCT00892580

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome

NCT01282268

Conditions
Autism Spectrum Disorder, Child Development Disorders, Pervasive, Chromosome Disorders, +14 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Research Administration Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 24 locations
View Trial Details
Completed

Comparison of Aneuploidy Risk Evaluations

NCT01663350

Conditions
Abnormalities, Multiple, Cardiovascular Abnormalities, Cardiovascular Diseases, +29 more
Locations
  • West Coast OB/GYN San Diego, California, United States
  • AD Williams Laboratory Atlanta, Georgia, United States
  • Prentice Women's Hospital Chicago, Illinois, United States
  • William Beaumont Hospital Royal Oak, Michigan, United States
View all 26 locations
View Trial Details

Related conditions